TSP Capital Management Group’s Novo Nordisk NVO Stock Holding History

TSP Capital Management Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-29,550	Closed	-$858K	–	67
2015 Q4	$858K	Hold	29,550	–	–	0.46%	48
2015 Q3	$801K	Hold	29,550	–	–	0.45%	45
2015 Q2	$809K	Buy	+29,550	New	+$831K	0.38%	51
2015 Q1	–	Hold	0	–	–	–	50
2014 Q4	–	Hold	0	–	–	–	53
2014 Q3	–	Sell	-30,150	Closed	-$694K	–	51
2014 Q2	$696K	Buy	+30,150	New	+$666K	0.3%	52
2014 Q1	–	Hold	0	–	–	–	53
2013 Q4	–	Hold	0	–	–	–	55
2013 Q3	–	Hold	0	–	–	–	56
2013 Q2	–	Hold	0	–	–	–	57

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

TSP Capital Management Group's NVO Position: Q1 2016 in Review

TSP Capital Management Group sold out of Novo Nordisk (NVO) in Q1 2016, closing a stake of 29,550 shares — an estimated $858K sold.

TSP Capital Management Group first reported a position in NVO in Q2 2014 and held it in 4 quarters. The position peaked at $858K in Q4 2015. 535 funds tracked by Wall St. Rank hold NVO as of Q1 2016.

TSP Capital Management Group reported no remaining Novo Nordisk position as of Q1 2016 after selling out during the quarter.
TSP Capital Management Group sold 29,550 Novo Nordisk shares in Q1 2016, an estimated $858K.
TSP Capital Management Group first reported a position in Novo Nordisk in Q2 2014 and held it in 4 quarters.
TSP Capital Management Group's Novo Nordisk position peaked at $858K in Q4 2015.
535 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2016.

Based on TSP Capital Management Group's 13F filing for Q1 2016, filed 12 May 2016.